Angiotensin II antagonists

This invention provides pharmaceutical heterocyclic derivatives of the formula in which R3 are specified nitrogen-containing fused rings. They antagonize angiotensin II receptors in mammals.

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	LIFER, SHERRYL LYNN, PALKOWITZ, ALAN DAVID, BOYD, DONALD BRADFORD, STEINBERG, MITCHELL IRVIN, MARSHALL, WINSTON STANLEY, PFEIFER, WILLIAM, REEL, JON KEVIN, SIMON, RICHARD LEE, VASUDEVAN, VENKATRAGHAVAN, THRASHER, KENNETH JEFF, WHITESITT, CELIA ANN
Format:	Patent
Sprache:	eng ; fre ; ger
Schlagworte:	ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	This invention provides pharmaceutical heterocyclic derivatives of the formula in which R3 are specified nitrogen-containing fused rings. They antagonize angiotensin II receptors in mammals.